![]() | |
Identifiers | |
---|---|
| |
CAS Number |
|
PubChemCID | |
IUPHAR/BPS | |
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard(EPA) | |
Chemical and physical data | |
Formula | C20H17F2N3O2 |
Molar mass | 369.372 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
ADX-47273 is a research pharmaceutical developed byAddex Therapeutics which acts as apositive allosteric modulator (PAM) selective for themetabotropic glutamate receptor subtypemGluR5.[1][2] It hasnootropic andantipsychotic effects in animal studies,[3] and has been used as alead compound to develop improved derivatives.[4]
![]() | Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |